WFI grade water for cell culture
Supports medium preparation with WFI-grade water optimal for pharmaceutical manufacturing.
In the field of cell culture, the quality of the culture medium has a significant impact on cell proliferation and function. In particular, the purity of the water used in medium preparation is a crucial factor that affects cell survival rates and product quality. Contamination with impurities can lead to inhibited cell growth and degradation of product quality. Our WFI-grade water is produced in a GMP-compliant manufacturing environment and has passed the quality tests of the Japanese Pharmacopoeia. This ensures that high-quality standards are met in medium preparation, allowing for safe use. 【Application Scenarios】 - Medium preparation in pharmaceutical manufacturing - Buffer preparation 【Benefits of Implementation】 - Improvement in pharmaceutical quality - Streamlining of manufacturing processes - Compliance with regulations
basic information
【Features】 - GMP-compliant manufacturing environment - Quality testing in accordance with the Japanese Pharmacopoeia - Certificate of analysis included - Customization available for bag capacity, tubes, and connectors - Colorless, clear, and odorless 【Our Strengths】 We provide contract manufacturing of liquid media and buffers for customers in cell therapy and biopharmaceuticals, all in compliance with GMP. Leveraging years of experience and advanced technology, we offer high-quality products tailored to meet our customers' needs.
Price range
Delivery Time
Applications/Examples of results
【Uses】 ■ Media preparation ■ Buffer preparation ■ Washing *For more details, please download the PDF or feel free to contact us.
catalog（3）
Download All Catalogs
Recommended products
Distributors
In June 2018, we established Ajinomoto Koji Bio Co., Inc. as a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Inc. We combined Ajinomoto Co., Inc.'s high-quality amino acids as the foundation for culture media raw materials and their formulation development technology with Koji Bio Co., Inc.'s advanced liquid culture media production technology to launch a contract manufacturing company for clinical culture media necessary for regenerative medicine. Currently, we are engaged in contract manufacturing of liquid media and buffers for customers in cell therapy and biopharmaceuticals, enhancing our significance in the industry.